EP3801552A4 - Zusammensetzung und verfahren zur inhalation - Google Patents
Zusammensetzung und verfahren zur inhalation Download PDFInfo
- Publication number
- EP3801552A4 EP3801552A4 EP19815062.5A EP19815062A EP3801552A4 EP 3801552 A4 EP3801552 A4 EP 3801552A4 EP 19815062 A EP19815062 A EP 19815062A EP 3801552 A4 EP3801552 A4 EP 3801552A4
- Authority
- EP
- European Patent Office
- Prior art keywords
- inhalation
- composition
- Prior art date
- Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
- Pending
Links
Classifications
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K9/00—Medicinal preparations characterised by special physical form
- A61K9/0012—Galenical forms characterised by the site of application
- A61K9/007—Pulmonary tract; Aromatherapy
- A61K9/0073—Sprays or powders for inhalation; Aerolised or nebulised preparations generated by other means than thermal energy
- A61K9/0075—Sprays or powders for inhalation; Aerolised or nebulised preparations generated by other means than thermal energy for inhalation via a dry powder inhaler [DPI], e.g. comprising micronized drug mixed with lactose carrier particles
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/557—Eicosanoids, e.g. leukotrienes or prostaglandins
- A61K31/5575—Eicosanoids, e.g. leukotrienes or prostaglandins having a cyclopentane, e.g. prostaglandin E2, prostaglandin F2-alpha
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K9/00—Medicinal preparations characterised by special physical form
- A61K9/14—Particulate form, e.g. powders, Processes for size reducing of pure drugs or the resulting products, Pure drug nanoparticles
- A61K9/16—Agglomerates; Granulates; Microbeadlets ; Microspheres; Pellets; Solid products obtained by spray drying, spray freeze drying, spray congealing,(multiple) emulsion solvent evaporation or extraction
- A61K9/1605—Excipients; Inactive ingredients
- A61K9/1617—Organic compounds, e.g. phospholipids, fats
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K9/00—Medicinal preparations characterised by special physical form
- A61K9/14—Particulate form, e.g. powders, Processes for size reducing of pure drugs or the resulting products, Pure drug nanoparticles
- A61K9/16—Agglomerates; Granulates; Microbeadlets ; Microspheres; Pellets; Solid products obtained by spray drying, spray freeze drying, spray congealing,(multiple) emulsion solvent evaporation or extraction
- A61K9/1605—Excipients; Inactive ingredients
- A61K9/1617—Organic compounds, e.g. phospholipids, fats
- A61K9/1623—Sugars or sugar alcohols, e.g. lactose; Derivatives thereof; Homeopathic globules
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61M—DEVICES FOR INTRODUCING MEDIA INTO, OR ONTO, THE BODY; DEVICES FOR TRANSDUCING BODY MEDIA OR FOR TAKING MEDIA FROM THE BODY; DEVICES FOR PRODUCING OR ENDING SLEEP OR STUPOR
- A61M15/00—Inhalators
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61M—DEVICES FOR INTRODUCING MEDIA INTO, OR ONTO, THE BODY; DEVICES FOR TRANSDUCING BODY MEDIA OR FOR TAKING MEDIA FROM THE BODY; DEVICES FOR PRODUCING OR ENDING SLEEP OR STUPOR
- A61M2202/00—Special media to be introduced, removed or treated
- A61M2202/06—Solids
- A61M2202/064—Powder
Landscapes
- Health & Medical Sciences (AREA)
- Life Sciences & Earth Sciences (AREA)
- Bioinformatics & Cheminformatics (AREA)
- Engineering & Computer Science (AREA)
- Public Health (AREA)
- General Health & Medical Sciences (AREA)
- Medicinal Chemistry (AREA)
- Pharmacology & Pharmacy (AREA)
- Epidemiology (AREA)
- Veterinary Medicine (AREA)
- Animal Behavior & Ethology (AREA)
- Chemical & Material Sciences (AREA)
- Biophysics (AREA)
- Molecular Biology (AREA)
- Otolaryngology (AREA)
- Pulmonology (AREA)
- Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
- Medicinal Preparation (AREA)
Applications Claiming Priority (2)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| US201862682109P | 2018-06-07 | 2018-06-07 | |
| PCT/US2019/036095 WO2019237028A1 (en) | 2018-06-07 | 2019-06-07 | Composition and method for inhalation |
Publications (2)
| Publication Number | Publication Date |
|---|---|
| EP3801552A1 EP3801552A1 (de) | 2021-04-14 |
| EP3801552A4 true EP3801552A4 (de) | 2022-02-23 |
Family
ID=68770678
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| EP19815062.5A Pending EP3801552A4 (de) | 2018-06-07 | 2019-06-07 | Zusammensetzung und verfahren zur inhalation |
Country Status (5)
| Country | Link |
|---|---|
| EP (1) | EP3801552A4 (de) |
| JP (1) | JP2021527058A (de) |
| AU (2) | AU2019282808B2 (de) |
| CA (1) | CA3102967A1 (de) |
| WO (1) | WO2019237028A1 (de) |
Families Citing this family (12)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| US9469600B2 (en) | 2013-10-25 | 2016-10-18 | Insmed Incorporated | Prostacyclin compounds, compositions and methods of use thereof |
| EP3452170A4 (de) | 2016-05-05 | 2020-04-01 | Liquidia Technologies, Inc. | Treprostinil in pulverform zur behandlung von pulmonaler hypertonie |
| CN119632930A (zh) | 2019-04-29 | 2025-03-18 | 英斯梅德股份有限公司 | 曲前列素前药的干粉组合物及其使用方法 |
| IL296567A (en) * | 2020-04-17 | 2022-11-01 | United Therapeutics Corp | Terfostinil for use in the treatment of interstitial lung disease |
| AU2021289336B2 (en) | 2020-06-09 | 2025-08-28 | Mannkind Corporation | Fumaryl diketopiperidine prodrugs of treprostinil |
| CN116437906B (zh) * | 2020-10-28 | 2026-07-03 | 英斯梅德股份有限公司 | 曲前列环素前药的干粉组合物和其使用方法 |
| JP7879112B2 (ja) * | 2020-11-17 | 2026-06-23 | ユナイテッド セラピューティクス コーポレイション | 肺高血圧向けの吸入式イマチニブ |
| AU2021396535A1 (en) * | 2020-12-07 | 2023-06-22 | Mannkind Corporation | Method and composition for treating pulmonary fibrosis |
| WO2022187352A1 (en) | 2021-03-03 | 2022-09-09 | United Therapeutics Corporation | A dry powder composition of trestinil and its prodrug thereof and further comprising comprising (e)-3,6-bis[4-(n-carbonyl-2-propenyl)amidobutyl]-2,5-diketopiperazine (fdkp) |
| CA3235985A1 (en) * | 2021-10-27 | 2023-05-04 | Mannkind Corporation | Methods and compositions for treating pulmonary hypertension |
| WO2023154705A1 (en) | 2022-02-08 | 2023-08-17 | United Therapeutics Corporation | Treprostinil iloprost combination therapy |
| WO2025160403A1 (en) * | 2024-01-24 | 2025-07-31 | Mannkind Corporation | Powder transport system |
Citations (1)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| US20140199398A1 (en) * | 2011-06-17 | 2014-07-17 | Mannkind Corporation | High capacity diektopiperazine microparticles and methods |
Family Cites Families (5)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| US5352461A (en) * | 1992-03-11 | 1994-10-04 | Pharmaceutical Discovery Corporation | Self assembling diketopiperazine drug delivery system |
| MX373000B (es) * | 2005-09-14 | 2020-05-21 | Mannkind Corp | Metodo para formulacion de farmaco basado en el aumento de la afinidad de agentes activos hacia las superficies de microparticulas cristalinas. |
| BR112015023168B1 (pt) * | 2013-03-15 | 2021-08-10 | Mannkind Corporation | Composição de 3,6-bis(n-fumaril-4-aminobutil)-2,5-dicetopiperazina cristalina, método de produção de partículas de 3,6-bis(n-fumaril-4-aminobutil)-2,5-dicetopiperazina e uso de uma composição de dicetopiperazina cristalina |
| IL260823B2 (en) * | 2016-01-29 | 2024-08-01 | Mannkind Corp | Dry powder inhaler |
| EP3452170A4 (de) * | 2016-05-05 | 2020-04-01 | Liquidia Technologies, Inc. | Treprostinil in pulverform zur behandlung von pulmonaler hypertonie |
-
2019
- 2019-06-07 CA CA3102967A patent/CA3102967A1/en active Pending
- 2019-06-07 WO PCT/US2019/036095 patent/WO2019237028A1/en not_active Ceased
- 2019-06-07 EP EP19815062.5A patent/EP3801552A4/de active Pending
- 2019-06-07 JP JP2020567883A patent/JP2021527058A/ja active Pending
- 2019-06-07 AU AU2019282808A patent/AU2019282808B2/en active Active
-
2025
- 2025-03-21 AU AU2025202053A patent/AU2025202053A1/en active Pending
Patent Citations (1)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| US20140199398A1 (en) * | 2011-06-17 | 2014-07-17 | Mannkind Corporation | High capacity diektopiperazine microparticles and methods |
Also Published As
| Publication number | Publication date |
|---|---|
| WO2019237028A1 (en) | 2019-12-12 |
| EP3801552A1 (de) | 2021-04-14 |
| CA3102967A1 (en) | 2019-12-12 |
| JP2021527058A (ja) | 2021-10-11 |
| AU2025202053A1 (en) | 2025-04-10 |
| AU2019282808B2 (en) | 2025-03-20 |
| AU2019282808A1 (en) | 2021-01-07 |
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| EP3850088A4 (de) | Zusammensetzungen und verfahren zur verbesserten basisbearbeitung | |
| EP3866924A4 (de) | Zusammensetzungen und verfahren zur antikörperfreisetzung | |
| EP3490622C0 (de) | Verfahren und zusammensetzungen zur wundheilung | |
| EP3704254A4 (de) | Cas12c-zusammensetzungen und verfahren zur verwendung | |
| EP3844553C0 (de) | Verfahren und system zur blickkalkulation | |
| EP3445251A4 (de) | Biopsievorrichtungen und verfahren zur verwendung davon | |
| EP3551033A4 (de) | Endoskop und verfahren zur verwendung | |
| EP3478723A4 (de) | Pd-l1-s-spezifische antikörper und verfahren zur verwendung davon | |
| EP3484469A4 (de) | Zusammensetzungen und verfahren zur verstärkung von antimikrobiata | |
| EP3720378C0 (de) | Katheter und verfahren zur katheteranordnung | |
| EP3599854A4 (de) | Pyrrolidinone und verfahren zur herstellung davon | |
| EP4745248A2 (de) | System und verfahren zur sequenzierung | |
| EP3640333A4 (de) | System und verfahren zur geneditierung | |
| EP3558303A4 (de) | Aminosäureverbindungen und verfahren zur verwendung | |
| EP3796894A4 (de) | Verfahren und zusammensetzungen zur genom-editierung | |
| EP3558502A4 (de) | Umkehrosmosemembran und verfahren zur verwendung | |
| EP3534710A4 (de) | Beschichtungszusammensetzungen und verfahren zur verwendung davon | |
| EP3710588A4 (de) | Zusammensetzungen und verfahren zur hemmung der aldh2-expression | |
| EP3733650C0 (de) | Verfahren zur herstellung eines elagolix-zwischenprodukts und zusammensetzung davon | |
| EP3416536C0 (de) | Winguide und verfahren zur verwendung davon | |
| EP3512423A4 (de) | System und verfahren zur charakterisierung von atemstress | |
| DE112018000901A5 (de) | Verfahren und Vorrichtung zur Beatmung | |
| EP3506982A4 (de) | Mif-hemmer und verfahren zur verwendung | |
| EP3851466A4 (de) | Polyoxymethylen und verfahren zur herstellung davon | |
| EP3687628A4 (de) | Zusammensetzungen und verfahren zur hemmung von acss2 |
Legal Events
| Date | Code | Title | Description |
|---|---|---|---|
| STAA | Information on the status of an ep patent application or granted ep patent |
Free format text: STATUS: THE INTERNATIONAL PUBLICATION HAS BEEN MADE |
|
| PUAI | Public reference made under article 153(3) epc to a published international application that has entered the european phase |
Free format text: ORIGINAL CODE: 0009012 |
|
| STAA | Information on the status of an ep patent application or granted ep patent |
Free format text: STATUS: REQUEST FOR EXAMINATION WAS MADE |
|
| 17P | Request for examination filed |
Effective date: 20201214 |
|
| AK | Designated contracting states |
Kind code of ref document: A1 Designated state(s): AL AT BE BG CH CY CZ DE DK EE ES FI FR GB GR HR HU IE IS IT LI LT LU LV MC MK MT NL NO PL PT RO RS SE SI SK SM TR |
|
| AX | Request for extension of the european patent |
Extension state: BA ME |
|
| DAV | Request for validation of the european patent (deleted) | ||
| DAX | Request for extension of the european patent (deleted) | ||
| REG | Reference to a national code |
Ref country code: HK Ref legal event code: DE Ref document number: 40049543 Country of ref document: HK |
|
| A4 | Supplementary search report drawn up and despatched |
Effective date: 20220124 |
|
| RIC1 | Information provided on ipc code assigned before grant |
Ipc: A61M 15/00 20060101ALI20220118BHEP Ipc: A61K 31/5575 20060101ALI20220118BHEP Ipc: A61K 9/16 20060101ALI20220118BHEP Ipc: A61K 9/48 20060101ALI20220118BHEP Ipc: A61K 9/00 20060101ALI20220118BHEP Ipc: A61K 31/557 20060101AFI20220118BHEP |
|
| P01 | Opt-out of the competence of the unified patent court (upc) registered |
Effective date: 20230506 |
|
| STAA | Information on the status of an ep patent application or granted ep patent |
Free format text: STATUS: EXAMINATION IS IN PROGRESS |
|
| 17Q | First examination report despatched |
Effective date: 20240131 |